Premature Rupture of Fetal Membranes
8
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
PGE2 Followed by Oxytocin vs Oxytocin in Term PROM (POXY-PROM)
Group B Streptococcus Infection and PROM Incidince
Balloon + Oxytocin Versus Oral Misoprostol to Induce Labor in Case of PROM (RUBAPRO2)
Evaluation of CRB in PROM Patients
Predictive Score for Neonatal Mortality for Women With Premature Rupture of Membranes Between 22 and 28 Weeks of Gestation
Does Nipple Stimulation Shorten Time to Vaginal Birth in Women With Term PROM?
Oxytocin vs. Prostaglandin for Induction of Labor in Primiparas With Prelabor Rupture of Membrane and Low Bishop
Monitoring of the Inflammatory Response of Patients With Premature Rupture of Membranes With Bedside Tests